Locoregional Recurrence Patterns in Patients With Different Molecular Subtypes of Breast Cancer

Author:

Cheun Jong-Ho1,Kim Hong-Kyu234,Moon Hyeong-Gon234,Han Wonshik234,Lee Han-Byoel234

Affiliation:

1. Seoul Metropolitan Government–Seoul National University Boramae Medical Center, Seoul, South Korea

2. Department of Surgery, Seoul National University College of Medicine, Seoul, South Korea

3. Biomedical Research Institute, Seoul National University Hospital, Seoul, Republic of Korea

4. Cancer Research Institute, Seoul National University, Seoul, Republic of Korea

Abstract

ImportanceWhile numerous studies have consistently reported that the molecular subtypes of breast cancer (BC) are associated with different patterns of distant metastasis, few studies have investigated the association of tumor subtypes with locoregional recurrence.ObjectiveTo investigate the patterns of ipsilateral breast tumor recurrence (IBTR), regional recurrence (RR), and contralateral BC (CBC) according to tumor subtypes.Design, Setting, and ParticipantsThis retrospective cohort study used the clinical records of patients who underwent BC surgery at a single institution in South Korea between January 2000 and December 2018. Data were analyzed from May 1, 2019, to February 20, 2023.ExposuresIpsilateral breast tumor recurrence, RR, and CBC events.Main Outcomes and MeasuresThe primary outcome was differences in annual incidence patterns of IBTR, RR, and CBC according to tumor subtypes. Hormone receptor (HR) status was assessed by immunohistochemical staining assay, and ERBB2 status was evaluated according to American Society of Clinical Oncology and College of American Pathologists guidelines.ResultsA total of 16 462 female patients were included in the analysis (median age at time of operation, 49.0 years [IQR, 43.0-57.0 years]). The 10-year IBTR-, RR-, and CBC-free survival rates were 95.9%, 96.1%, and 96.5%, respectively. On univariate analysis, HR−/ERBB2+ tumors had the worst IBTR-free survival (vs HR+/ERBB2− subtype: adjusted hazard ratio, 2.95; 95% CI, 2.15-4.06), while the HR−/ERBB2– subtype had the worst RR- and CBC-free survival among all subtypes (vs HR+/ERBB2− subtype, RR: adjusted hazard ratio, 2.95; 95% CI, 2.37-3.67; CBC: adjusted hazard ratio, 2.12; 95% CI, 1.64-2.75). Subtype remained significantly associated with recurrence events in Cox proportional hazards regression analysis. Regarding the annual recurrence pattern, the IBTR patterns of HR−/ERBB2+ and HR−/ERBB2− subtypes showed double peaks, while HR+/ERBB2− tumors showed a steadily increasing pattern without distinguishable peaks. Additionally, the HR+/ERBB2− subtype seemed to have a steady RR pattern, but other subtypes showed the highest RR incidence at 1 year following surgery, which then gradually decreased. The annual recurrence incidence of CBC gradually increased among all subtypes, and patients with the HR−/ERBB2− subtype had a higher incidence than patients with other subtypes over 10 years. Younger patients (age ≤40 years) had greater differences in IBTR, RR, and CBC patterns between subtypes than did older patients.Conclusions and RelevanceIn this study, locoregional recurrence occurred with different patterns according to BC subtypes, with younger patients having greater differences in patterns among subtypes than older patients. The findings suggest that tailoring surveillance should be recommended regarding differences in locoregional recurrence patterns according to tumor subtypes, particularly for younger patients.

Publisher

American Medical Association (AMA)

Subject

Surgery

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3